Patient Rating:

No Rating Available?

Anupam R. Verma, M.D.

Patient Rating:

No Rating Available?

Specialties

Languages

  • English
  • Hindi

Clinical Details

Phone Number Clinical Office Address
(801) 662-4700 Primary Children's Hospital
100 N Mario Capecchi Drive
Salt Lake City, UT 84113

Bio

Anupam Verma, MD, is an assistant professor and physician in the Division of Pediatric Hematology and Oncology at the University of Utah, an investigator at the Huntsman Cancer Institute (HCI), and a member of the Experimental Therapeutics program. In her clinical work at Primary Children’s Medical Center, she cares for children with blood diseases and cancers.

As a researcher, Verma is involved in developing and conducting early phase clinical trials for children with leukemia and lymphomas. At HCI, her research focus is novel target drug development to advance cures for pediatric cancer.

Verma is board-certified in pediatrics and recently completed a fellowship in pediatric hematology and oncology at the University of Utah and Primary Children’s Medical Center. She has been an assistant professor of pediatrics at the University of Utah School of Medicine since 2009. Verma completed her pediatric residency at Brookdale University Hospital and Medical Center in Brooklyn, New York. She worked as a senior resident doctor in pediatrics at All India Institute of Medical Sciences in New Delhi, India. She received her medical degree and her doctorate in pediatrics from Baroda Medical College, India.

Board Certification and Academic Information

Academic Departments Pediatrics - Assistant Professor (Clinical)
Academic Divisions Pediatric Hematology/Oncology
Board Certification American Board of Pediatrics (Pediatrics)
Indian Board of Pediatrics
American Board of Pediatrics (Sub: Ped Hematology-Oncology)

Academic Profile

Board Certification and Academic Information

Academic Departments Pediatrics - Assistant Professor (Clinical)
Academic Divisions Pediatric Hematology/Oncology
Board Certification American Board of Pediatrics (Pediatrics)
Indian Board of Pediatrics
American Board of Pediatrics (Sub: Ped Hematology-Oncology)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 662-1000 Primary Children's Hospital
100 N Mario Capecchi Drive
Salt Lake City, UT 84113

Academic Bio

Anupam Verma, MD, is an assistant professor and physician in the Division of Pediatric Hematology and Oncology at the University of Utah, and an investigator at the Huntsman Cancer Institute (HCI), and a member of the Experimental Therapeutics program. In her clinical work at Primary Children’s Medical Center, she cares for children with blood diseases and cancers.

As a researcher, Verma is involved in developing and conducting early phase clinical trials for children with leukemia and lymphomas. At HCI, her research focus is novel target drug development to advance cures for pediatric cancer.

Verma is board-certified in pediatrics and recently completed a fellowship in pediatric hematology and oncology at the University of Utah and Primary Children’s Medical Center. She has been an assistant professor of pediatrics at the University of Utah School of Medicine since 2009. Verma completed her pediatric residency at Brookdale University Hospital and Medical Center in Brooklyn, New York. She worked as a senior resident doctor in pediatrics at All India Institute of Medical Sciences in New Delhi, India. She received her medical degree and her doctorate in pediatrics from Baroda Medical College, India.

Education

Education History

Type School Degree
Fellowship University of Utah
Pediatric Hematology/Oncology
Fellow
Chief Resident Brookdale University Hospital Medical Center
Pediatrics
Chief Resident
Residency Brookdale University Hospital Medical Center
Pediatrics
Resident
Residency University of Baroda Medical College
Pediatrics
Resident
Professional Medical University of Baroda Medical College
Medicine
M.B.B.S.

Publications

Selected Provider Publications

Journal Article

  1. Raffaella Soldi, Stephen K Horrigan, Marek W Cholody, Janak Padia, Venkataswamy Sorna, Jared Bearss, Glynn Gilcrease, Kapil Bhalla, Anupam Verma, Hariprasad Vankayalapati, and Sunil Sharma (7/16/2015). Design, Synthesis, and Biological Evaluation of a Series of Anthracene-9,10-dione Dioxime β-Catenin Pathway Inhibitors. J Med Chem.
  2. Mangum DS1, Verma A, Weng C, Sheng X, Larsen R, Kirchhoff AC, Druzgal C, Fluchel M (November, 2013). A comparison of central lines in pediatric oncology patients: Early removal and patient centered outcomes. Pediatr Blood Cancer.
  3. Mollard A, Warner SL, Call LT, Wade ML, Bearss JJ, Verma A, Sharma S, Vankayalapati H, Bearss DJ (12/08/2011). Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors. ACS Medicinal Chemistry Letters, 2(12), 901-912.
  4. Verma A, Zhou H, Chin S, Bruggers C, Kestle J, Khatua S (12/20/2011). EGFR as a predictor of relapse in myxopapillary ependymoma. Pediatr Blood Cancer.
  5. Everitt MD, Verma AR, Saarel EV (Sept 2011). The wearable external cardiac defibrillator for cancer patients at risk for sudden cardiac death. Community Oncology, 8(9), 400-403.
  6. Verma AR, OP Shukla (2004). Usher's Syndrome. Indian Journal of Otolaryngology and Head and Neck Surgery, 56, 119-121.

Review

  1. Glade Bender J, Verma A, Schiffman JD (February, 2015). Translating genomic discoveries to the clinic in pediatric oncology. [Review]. Current Opinion in Pediatrics.
  2. Verma A, Warner SL, Vankayalapati H, Bearss DJ, Sharma S (09/20/2011). Targeting Axl and Mer Kinases in Cancer. [Review]. Molecular Cancer Therapeutics, (Oct 2011), 1763-73.

Letter

  1. Mollard A, Warner SL, Call L, Wade M, Bearss J, Verma AR, Sharma S, Bearss DJ, Vankayalapati H (April 2011). Homology structure-based design, synthesis and biological evaluation of a series of novel Axl and Mer kinase Inhibitors [Letter to the editor]. ACS Med Chem Lett, 12(2), 907-912.

Poster

  1. A Ast, A Putnam, J Schiffman, A Hill, E Perlman, S South, C Paxton, A Verma (May, 2015). DICER1 showing its ugly face again. A novel DICER1 mutation identified in a female with an undifferentiated renal sarcoma with cystic nephroma background. Poster session presented at ASPHO, Phoenix, AZ.
  2. Michael J Burke, Patrick Brown, Lia Gore, Richard Sposto, Deepa Bhojwani, Bill H Chang, Steven G Dubois, Paul S Gaynon, Julia Glade-Bender, Kenneth Matthew Heym, Maria Luisa Sulis, Jessica A Pollard, Anupam Verma, and Van Huynh (2014). Invasive Candida Infections in Pediatric Patients Treated on the Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium. Poster session presented at 56th ASH Annual Meeting and Exposition, San Francisco.
  3. Verma A, Frazer JK, Trakhimets A, Heaton W, Bearrs J, Warner S, Bearrs D, Sharma S (Dec 2011). A Novel Dual AXL/Mertk and Aurora Kinase Inhibiton Active Against T Cell Acute Lymphoblastic Leukemia. Poster session presented at 53rd ASH Annual Meeting, San Diego, CA.
  4. Verma AR, Fluchel M, Barnette P (Oct 18-20, 2011). Familial Hemophagocytic Lymphohistiocytosis presenting with Nonimmune Hydrops Fetalis.
  5. Verma AR, Rodgers G, Yaish H (Dec 3-7, 2010). Type 3 Von Willebrand Disease with Alloantibodies and Its Challenging Management During Episode of Bleeding. Poster session presented at ASH, Orange County, FL.
  6. Verma A, Zhou H, Chin S, Bruggers C, Kestle J, Khatua S (Nov 18-21, 2010). EGFR as a predictor of relapse and a potential therapeutic target in recurrent disseminated myxopapillary ependymoma. Poster session presented at SNO, Montreal, QC, Canada.
  7. Mangum DS, Verma AR, Druzgal C, Larsen R, Fluchel M (04/08/2010). External Venous Catheters Have a Higher Rate of Early Removal than Subcutaneous Ports in Pediatric Cancer Patients. Poster session presented at American Society of Pediatric Hematology / Oncology, Montreal, QC, Canada.
  8. Verma AR, Mangum DS, Druzgal C, Owen C, Collingridge D, Fluchel M (04/09/2010). Subcutaneous Ports Versus External Venous Catheters from the Perspective of Pediatric Oncology Patients and their Families. Poster session presented at American Society of Pediatric Hematology / Oncology, Montreal, QC, Canada.

Clinical Trials

Clinical Trials

Video & News